Our Pharmacy Partners
Good Girl Rx works with licensed U.S. compounding pharmacies that operate under state and federal regulations.
503A Compounding Pharmacies:
Licensed by state boards of pharmacy
Compound medications based on patient-specific prescriptions from licensed providers
Required to comply with USP (United States Pharmacopeia) standards
Subject to state regulatory oversight and inspections
What "Compounded" Means
A compounded medication is prepared by a licensed pharmacist based on a prescription for an individual patient. This is NOT a generic version of a brand-name drug.
Compounded GLP-1 medications:
Contain the same active pharmaceutical ingredient (API) as brand-name versions
Are prepared in a licensed pharmacy setting
Are made specifically for you based on your provider's prescription
Are NOT FDA-approved as finished products (important distinction below)
Important: FDA Approval Status
Brand-name medications (Ozempic, Wegovy, Mounjaro, Zepbound) are FDA-approved finished products manufactured by pharmaceutical companies that have undergone FDA review for safety, efficacy, and manufacturing quality.
Compounded medications are NOT FDA-approved as finished products. The FDA does not review compounded medications the same way it reviews manufactured drugs. However:
The active ingredients used must meet USP standards or be components of FDA-approved products
The compounding pharmacy must be licensed and inspected by state boards of pharmacy
The pharmacy must follow USP compounding standards (USP <795> and <797> for sterile compounding)
What this means for you: Compounded medications can serve an important role for patients, but they do not have the same regulatory assurances as FDA-approved manufactured medications. Your provider has determined that compounded medication is appropriate for your care, but you should be aware of this distinction.
Regulatory Status Updates
The regulatory landscape for compounded GLP-1 medications has changed significantly. Both semaglutide and tirzepatide are no longer on the FDA drug shortage list.
Current status (as of this writing):
Compounding of these medications continues under 503A regulations
Patient-specific prescriptions are required
Compounded medications must not be "essentially copies" of commercially available products unless a clinical justification exists (such as an allergy to an inactive ingredient)
Our pharmacy partners and providers stay current with all regulatory requirements. Your treatment is prescribed and fulfilled in compliance with applicable federal and state regulations.
Quality Assurance
Our pharmacy partners maintain:
State licensure and good standing with boards of pharmacy
Compliance with USP compounding standards
Quality control procedures for every preparation
Proper storage and handling protocols
Temperature-controlled shipping for stability
If you have questions about the specific pharmacy filling your prescription, contact support.